Additionally, [pIC]PEI, which aids in cytoplasmic delivery of polyinosinic-polycytidylic acid and Nifurtimox, has promising therapeutic effects in pancreatic cancers by modulating immune cell response within the IFN-γ/STAT1 pathway. Here, STAT1 is linked to pancreatic neoplasm.